cis-Acting effects on RNA processing and Drosha cleavage prevent Epstein-Barr virus latency III BHRF1 expression

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 8929-8939

  Xing, Li ^a,b,c   Kieff, Elliott ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; PROTEIN BHRF1; RNA POLYMERASE II; UNCLASSIFIED DRUG; VIRUS PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; MOLECULAR DYNAMICS; NONHUMAN; PLASMID; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA PROCESSING; START CODON; TRANSCRIPTION INITIATION SITE; VIRUS LATENCY; VIRUS REPLICATION;

CELL LINE; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; RIBONUCLEASE III; RNA PROCESSING, POST-TRANSCRIPTIONAL; VIRAL PROTEINS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 80052278193     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00336-11     Document Type: Article

References (59)

1. Alfieri, C., M. Birkenbach, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608.
2. Altmann, M., and W. Hammerschmidt. 2005. Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol. 3:e404.
3. Austin, P. J., E. Flemington, C. N. Yandava, J. L. Strominger, and S. H. Speck. 1988. Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 85:3678-3682.
4. Ballarino, M., et al. 2009. Coupled RNA processing and transcription of intergenic primary microRNAs. Mol. Cell. Biol. 29:5632-5638.
5. Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
6. Cai, X., C. H. Hagedorn, and B. R. Cullen. 2004. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10:1957-1966.
7. Cai, X., et al. 2006. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2:e23.
8. Callard, R. E., et al. 1988. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23). Immunology 65:379-384.
9. Carthew, R. W., and E. J. Sontheimer. 2009. Origins and mechanisms of miRNAs and siRNAs. Cell 136:642-655.
10. Chen, L. L., and G. G. Carmichael. 2010. Decoding the function of nuclear long non-coding RNAs. Curr. Opin. Cell Biol. 22:357-364.
11. Chendrimada, T. P., et al. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436:740-744.
12. Cheng, H., et al. 2006. Human mRNA export machinery recruited to the 5′ end of mRNA. Cell 127:1389-1400.
13. Chou, S. P., C. H. Tsai, L. Y. Li, M. Y. Liu, and J. Y. Chen. 2004. Characterization of monoclonal antibody to the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2. Hybrid. Hybridomics 23:29-37.
14. Cleary, M. L., S. D. Smith, and J. Sklar. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28.
15. Cox, M. A., J. Leahy, and J. M. Hardwick. 1990. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64:313-321.
16. Cullen, B. R. 2004. Transcription and processing of human microRNA precursors. Mol. Cell 16:861-865.
17. Das, R., et al. 2006. Functional coupling of RNAP II transcription to spliceosome assembly. Genes Dev. 20:1100-1109.
18. Desbien, A. L., J. W. Kappler, and P. Marrack. 2009. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. Proc. Natl. Acad. Sci. U. S. A. 106:5663-5668.
19. Edwards, R. H., A. R. Marquitz, and N. Raab-Traub. 2008. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J. Virol. 82:9094-9106.
20. Eiring, A. M., et al. 2010. miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 140:652-665.
21. Feederle, R., et al. 2011. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog. 7:e1001294.
22. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-74.
23. Han, J., et al. 2006. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125:887-901.
24. Han, J., et al. 2009. Posttranscriptional crossregulation between Drosha and DGCR8. Cell 136:75-84.
25. Hutvágner, G., et al. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293:834-838.
26. Hwang, H. W., E. A. Wentzel, and J. T. Mendell. 2007. A hexanucleotide element directs microRNA nuclear import. Science 315:97-100.
27. Jones, C. 2003. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev. 16:79-95.
28. Kelly, G. L., et al. 2009. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link. PLoS Pathog. 5:e1000341.
29. Kieff, E., and A. B. Rickinson. 2007. Epstein-Barr virus and its replication, p. 2603-2654. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins Publishers, Philadelphia, PA.
30. Kim, V. N., J. Han, and M. C. Siomi. 2009. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10:126-139.
31. Kim, Y. K., and V. N. Kim. 2007. Processing of intronic microRNAs. EMBO J. 26:775-783.
32. Kozak, M. 2005. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 361:13-37.
33. Kvansakul, M., et al. 2010. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog. 6:e1001236.
34. Lagos-Quintana, M., R. Rauhut, W. Lendeckel, and T. Tuschl. 2001. Identification of novel genes coding for small expressed RNAs. Science 294:853-858.
35. Lee, Y., et al. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425:415-419.
36. Lee, Y., et al. 2004. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23:4051-4060.
37. Le Hir, H., A. Nott, and M. J. Moore. 2003. How introns influence and enhance eukaryotic gene expression. Trends Biochem. Sci. 28:215-220.
38. Li, L. Y., M. Y. Liu, H. M. Shih, C. H. Tsai, and J. Y. Chen. 2006. Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival. J. Gen. Virol. 87:2869-2878.
39. Li, L. Y., H. M. Shih, M. Y. Liu, and J. Y. Chen. 2001. The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J. Biol. Chem. 276:27354-27362.
40. Moore, M. J., and N. J. Proudfoot. 2009. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 136:688-700.
41. Morin, R. D., et al. 2008. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 18:610-621.
42. Morlando, M., et al. 2008. Primary microRNA transcripts are processed co-transcriptionally. Nat. Struct. Mol. Biol. 15:902-909.
43. Orphanides, G., and D. Reinberg. 2002. A unified theory of gene expression. Cell 108:439-451.
44. Pearson, G. R., et al. 1987. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. Virology 160:151-161.
45. Perales, R., and D. Bentley. 2009. "Cotranscriptionality": the transcription elongation complex as a nexus for nuclear transactions. Mol. Cell 36:178-191.
46. Pfeffer, S., et al. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2:269-276.
47. Pfeffer, S., et al. 2004. Identification of virus-encoded microRNAs. Science 304:734-736.
48. Pfitzner, A. J., E. C. Tsai, J. L. Strominger, and S. H. Speck. 1987. Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome. J. Virol. 61:2902-2909.
49. Proudfoot, N. J., A. Furger, and M. J. Dye. 2002. Integrating mRNA processing with transcription. Cell 108:501-512.
50. Rickinson, A. B., and E. Kieff. 2007. Epstein-Barr virus, p. 2655-2700. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins Publishers, Philadelphia, PA.
51. Roy, S. W., and W. Gilbert. 2006. The evolution of spliceosomal introns: patterns, puzzles and progress. Nat. Rev. Genet. 7:211-221.
52. Seto, E., et al. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog. 6:e1001063.
53. Shenoy, A., and R. Blelloch. 2009. Genomic analysis suggests that mRNA destabilization by the microprocessor is specialized for the auto-regulation of Dgcr8. PLoS One 4:e6971.
54. Takada, K., et al. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156.
55. Watanabe, A., et al. 2010. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. J. Virol. 84:2893-2901.
56. Xia, T., et al. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 68:1436-1442.
57. Xing, L., and E. Kieff. 2007. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J. Virol. 81:9967-9975.
58. Yewdell, J. W., and C. V. Nicchitta. 2006. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol. 27:368-373.
59. Zhu, J., et al. 2010. A novel role for minimal introns: routing mRNAs to the cytosol. PLoS One 5:e10144.